0001209191-22-019254.txt : 20220316 0001209191-22-019254.hdr.sgml : 20220316 20220316164412 ACCESSION NUMBER: 0001209191-22-019254 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220315 FILED AS OF DATE: 20220316 DATE AS OF CHANGE: 20220316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ahmadzai David CENTRAL INDEX KEY: 0001813060 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12537 FILM NUMBER: 22745429 MAIL ADDRESS: STREET 1: 3525 PIEDMONT RD., NE STREET 2: BUILDING 6, SUITE 700 CITY: ATLANTA STATE: GA ZIP: 30305 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEXTGEN HEALTHCARE, INC. CENTRAL INDEX KEY: 0000708818 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 952888568 STATE OF INCORPORATION: CA FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 3525 PIEDMONT RD., NE STREET 2: BUILDING 6, SUITE 700 CITY: ATLANTA STATE: GA ZIP: 30305 BUSINESS PHONE: 404-467-1500 MAIL ADDRESS: STREET 1: 3525 PIEDMONT RD., NE STREET 2: BUILDING 6, SUITE 700 CITY: ATLANTA STATE: GA ZIP: 30305 FORMER COMPANY: FORMER CONFORMED NAME: QUALITY SYSTEMS, INC DATE OF NAME CHANGE: 20180823 FORMER COMPANY: FORMER CONFORMED NAME: NEXTGEN HEALTHCARE, INC DATE OF NAME CHANGE: 20180823 FORMER COMPANY: FORMER CONFORMED NAME: QUALITY SYSTEMS, INC DATE OF NAME CHANGE: 20100804 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-15 0 0000708818 NEXTGEN HEALTHCARE, INC. NXGN 0001813060 Ahmadzai David 3525 PIEDMONT RD., NE BUILDING 6, SUITE 700 ATLANTA GA 30305 0 1 0 0 Chief Accounting Officer Common Stock 2022-03-15 4 M 0 3250 16.37 A 47772 D Common Stock 2022-03-15 4 M 0 3000 16.83 A 50772 D Common Stock 2022-03-15 4 S 0 6250 19.5525 D 44522 D Stock Option (right to buy) 16.37 2022-03-15 4 M 0 3250 0.00 D 2025-06-13 Common Stock 3250 6000 D Stock Option (right to buy) 16.83 2022-03-15 4 M 0 3000 0.00 D 2026-06-01 Common Stock 3000 3000 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.55 to $19.561. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request. Original grant of 13,000 options granted on 6/13/2017 vested in four equal, annual installments beginning 6/13/2018. Original grant of 12,000 options granted on 5/30/2018 vests in four equal, annual installments beginning 6/1/2019. Options exercised vested on 6/1/2021. Remaining 3,000 options will vest on 6/1/2022. /s/ Jeffrey D. Linton, Attorney-in-Fact for David Ahmadzai 2022-03-16